Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of the 'ExoDx Prostate IntelliScore' in Men Presenting for Initial Biopsy; Additional Confirmation Study Including Impact on Decision-making and Health Economics.

NCT03031418 is registered in ClinicalTrials.gov with Exosome Diagnostics, Inc. as lead sponsor.

NCT NCT03031418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03031418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of the 'ExoDx Prostate IntelliScore' in Men Presenting for Initial Biopsy; Additional Confirmation Study Including Impact on Decision-making and Health Economics.
Lead sponsor
Exosome Diagnostics, Inc.
Phase
Observational
Overall status
Completed
Start date
September 1, 2016
Completion date
September 1, 2018
Enrollment
532 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of prostate